| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |